In this issue of Cell Reports, Li et al. show that the analysis of genetic changes in patient-derived xenografts can reveal crucial details of tumor evolution, such as the emergence of functional estrogen receptor mutations in endocrine-resistant breast cancer
AbstractPatient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the ...
Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical stud...
The cancer genomics revolution has rapidly expanded the inventory of somatic mutations characterizin...
In this issue of Cell Reports, Li et al. show that the analysis of genetic changes in patient-derive...
Patient-derived xenografts (PDXs) have become a prominent cancer model system, as they are presumed ...
International audienceABSTRACT: INTRODUCTION: Identification of new therapeutic agents for breast ca...
To characterize patient-derived xenografts (PDXs) for functional studies, we made whole-genome compa...
The authors wish to thank the personnel of the IRCM animal facility team, the histology (RHEM) platf...
Massively parallel DNA sequencing technologies provide an unprecedented ability to screen entire gen...
Cancer develops due to the accumulation of genetic alterations and new insights in these alterations...
Breast cancer is the most common malignancy in women all over the world. Genetic background of women...
Estrogen receptor α-positive (ER-positive) or 'luminal' breast cancers were notoriously difficult to...
SummaryCancer genomics has provided an unprecedented opportunity for understanding genetic causes of...
AbstractPatient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the ...
Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical stud...
The cancer genomics revolution has rapidly expanded the inventory of somatic mutations characterizin...
In this issue of Cell Reports, Li et al. show that the analysis of genetic changes in patient-derive...
Patient-derived xenografts (PDXs) have become a prominent cancer model system, as they are presumed ...
International audienceABSTRACT: INTRODUCTION: Identification of new therapeutic agents for breast ca...
To characterize patient-derived xenografts (PDXs) for functional studies, we made whole-genome compa...
The authors wish to thank the personnel of the IRCM animal facility team, the histology (RHEM) platf...
Massively parallel DNA sequencing technologies provide an unprecedented ability to screen entire gen...
Cancer develops due to the accumulation of genetic alterations and new insights in these alterations...
Breast cancer is the most common malignancy in women all over the world. Genetic background of women...
Estrogen receptor α-positive (ER-positive) or 'luminal' breast cancers were notoriously difficult to...
SummaryCancer genomics has provided an unprecedented opportunity for understanding genetic causes of...
AbstractPatient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the ...
Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical stud...
The cancer genomics revolution has rapidly expanded the inventory of somatic mutations characterizin...